Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCLKallesh D. Jayappa, Michael J. Weber, Vicki L. Gordon et al.|Blood Advances|2017Cited by 116
Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanismsMark J. Axelrod, Michael J. Weber|Oncotarget|2013Cited by 47